Arcadia Biosciences, Inc. (RKDA) Free cash flow 2017–2025
Arcadia Biosciences, Inc. (RKDA) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$9.6MFY2025 · since FY2017: -$17.1M → -$9.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$9.6M | +37.1% |
| FY2024 | -$15.3M | -9.5% |
| FY2023 | -$14.0M | +46.1% |
| FY2022 | -$25.9M | +16.9% |
| FY2021 | -$31.2M | -59.9% |
| FY2020 | -$19.5M | -29.3% |
| FY2019 | -$15.1M | -6.3% |
| FY2018 | -$14.2M | +17.0% |
| FY2017 | -$17.1M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More RKDA financial trends
RKDA RevenueRKDA Net incomeRKDA Net marginRKDA Gross profitRKDA Gross marginRKDA Operating incomeRKDA Operating marginRKDA Operating cash flowRKDA Capital expendituresRKDA Return on equityRKDA Stock buybacksRKDA Dividends paidRKDA Total assetsRKDA Total liabilitiesRKDA Shareholders’ equityRKDA overview →